Galmed Pharmaceuticals Ltd (GLMD)
0.3925
-0.01
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
0.40
+0.01
(+1.91%)
Pre-Market: 08:09
Galmed Pharmaceuticals Free Cash Flow (Quarterly): -0.898M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.898M |
September 30, 2023 | -2.177M |
June 30, 2023 | -1.367M |
March 31, 2023 | -1.695M |
December 31, 2022 | -4.025M |
September 30, 2022 | -3.114M |
June 30, 2022 | -5.914M |
March 31, 2022 | -5.452M |
December 31, 2021 | -6.991M |
September 30, 2021 | -8.987M |
June 30, 2021 | -7.638M |
March 31, 2021 | -9.287M |
December 31, 2020 | -7.849M |
September 30, 2020 | -5.635M |
June 30, 2020 | -6.259M |
March 31, 2020 | -6.588M |
December 31, 2019 | -4.069M |
September 30, 2019 | -3.873M |
June 30, 2019 | -3.182M |
March 31, 2019 | -3.825M |
December 31, 2018 | -2.287M |
September 30, 2018 | -1.913M |
Date | Value |
---|---|
June 30, 2018 | -1.447M |
March 31, 2018 | -3.466M |
December 31, 2017 | -2.486M |
September 30, 2017 | -2.896M |
June 30, 2017 | -2.816M |
March 31, 2017 | -3.881M |
December 31, 2016 | -2.815M |
September 30, 2016 | -3.215M |
June 30, 2016 | -3.028M |
March 31, 2016 | -3.088M |
December 31, 2015 | -2.227M |
September 30, 2015 | -2.268M |
June 30, 2015 | -1.88M |
March 31, 2015 | -2.258M |
December 31, 2014 | -3.36M |
September 30, 2014 | -2.057M |
June 30, 2014 | -2.37M |
March 31, 2014 | -2.224M |
December 31, 2013 | -0.922M |
September 30, 2013 | -0.992M |
June 30, 2013 | -0.167M |
March 31, 2013 | -0.456M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.287M
Minimum
Mar 2021
-0.898M
Maximum
Dec 2023
-5.00M
Average
-5.452M
Median
Mar 2022
Free Cash Flow (Quarterly) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -3.77M |
BioLine Rx Ltd | 4.973M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -6.249M |